The findings from Fred Hutch Cancer Center suggest next step of exploring whether one dose of the vaccine is enough.

We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

In the first meeting of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) ...

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

A class action lawsuit was filed against Merck & Co. (MRK) by Levi & Korsinsky on February 12, 2025. The plaintiffs ...

The UK's MHRA has been redesignated as one of the WHO’s collaborating centres for the standardisation and evaluation of ...

Merck has a strong vaccine business, thanks to the human papillomavirus (HPV) products Gardasil and Gardasil 9. It's also a leader in the animal health business. However, its shares underperformed the ...

The case alleges Merck misrepresented the demand for its Gardasil vaccine in China, leading to distributor inventory overload. A U.S. District Court lawsuit claims Merck lacked real visibility into ...

GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1.

On July 30, 2024, Merck released its second quarter 2024 financial report and disclosed a significant reduction in Gardasil vaccinations, resulting in an overabundance of inventory at Merck's ...

On the other hand, Merck faces greater headwinds. Disappointing sales for its Gardasil vaccine against human papillomavirus (HPV), alongside uncertainty regarding the looming loss of patent ...